Skip to content
Home » HHT Continuing Education Program » Live On-Demand Learning » Disclosures

HHT CME On-Demand: Partnerships and Disclosures

Accreditation Information

In support of improving patient care, this activity has been planned and implemented by Cure HHT and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Disclosure Information

It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and mitigated.

All members of the CME department have nothing to disclose.

Speakers are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis.

These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the sponsor for CME credits.

Steering Committee Disclosures

  • Murali Chakinala, MD, FCCP
    • Research support/grants from Janssen, Bayer, Medtronic, United Therapeutics, Altavant Sciences, Trio Health Analytics, Acceleron / Merck, Gossamer, Respira Therapeutics, Vaderis Therapeutics, and Cure HHT / DOD.
    • Consultant and/or advisory committees for Express Scripts, Insmed Incorporated, United Therapeutics, Vaderis Therapeutics, Aerovate, Merck, Liquidia Technologies, Inc., and Janssen.
    • Compensation for activities performed from Pulmonary Hypertension Association, Cure HHT Foundation, and Janssen.
  • Miles Conrad, MD, MPH
    • Consultant and/or advisory committees for Medtronic.
  • Adrienne Hammill, MD, PhD
    • Research support/grants from Novartis, Merck, Protara, Venthera, Avalo, and Palvella.
    • Consultant and/or advisory committees for Novartis, Aytu BioPharma, Inc., Diagonal Therapeutics, Ipsen, and IDEAYA Biosciences.
  • Raj Kasthuri, MBBS
    • Consultant and/or advisory committees for Pharmacosmos Therapeutics.
  • Donna Ottensmeier
    • No financial relationships to disclose.
  • Marianne Clancy, MPA
    • No financial relationships to disclose.
  • Melissa Dickey, MSN, FNP
    • No financial relationships to disclose.
  • Nolie Krock, MSc
    • No financial relationships to disclose.

Content Creator and Content Reviewer Disclosures

  • Hanny Al-Samkari, MD
    • Research support/grants from Agios, Sobi, Novartis, Vaderis, Amgen.
    • Consultant and/or advisory committees for Agios, Sobi, argenx, Pharmacosmos, Forma, Novartis, Moderna.
  • John Battaile, MD
    • No financial relationships to disclose.
  • Mark Chesnutt, MD
    • No financial relationships to disclose.
  • Marie Faughnan, MD
    • Consultant and/or advisory committees for Ipsen, Guidepoint.
  • Jim Gossage, MD
    • Consultant and/or advisory committees for Vaderis.
  • Kate Henderson, MD
    • No financial relationships to disclose.
  • Steven Hetts, MD
    • Research support/grants from Route 92, Stryker, Siemens.
    • Consultant and/or advisory committees for Imperative Care, Cerenovus, MicroVention Terumo.
    • Compensation for activities performed for Filtro, Inc., ThrombX, Inc.
  • Peter Hountras, MD
    • Consultant and/or advisory committees for Gossamer Bio, Jansen Pharmaceuticals, Bayer, Caladrius, United Therapeutics.
  • Vivek Iyer, MD
    • No financial relationships to disclose.
  • Patricia Loftus, MD
    • No financial relationships to disclose.
  • Mollie Meek, MD
    • No financial relationships to disclose.
  • Joseph Parambil, MD
    • No financial relationships to disclose.
  • Jay Piccirillo, MD
    • No financial relationships to disclose.
  • Allyson Pishko, MD
    • Research support/grants from Sanofi Genzyme, Anthos Therapeutics.
    • Consultant and/or advisory committees for Biomarin.
    • Compensation for activities performed for UptoDate, American Society of Hematology and Lymphoma, Leukemia, Myeloma Congress.
  • David Poetker, MD
    • Compensation for activities performed for Badger Dental Products, LLC.
  • Jeffrey Pollak, MD
    • No financial relationships to disclose.
  • Edda Spiekerkoetter, MD
    • No financial relationships to disclose.
  • David Stevenson, MD
    • Consultant and/or advisory committees for Alexion, Biomarin, GLC, Novartis, BMJ Best Practice, Lamar Health Inc (future stock options).
  • Andrew White, MD
    • No financial relationships to disclose.
  • Kevin Whitehead, MD
    • No financial relationships to disclose.

All disclosures have been mitigated.

Transparency to Learners

Cure HHT is the sponsor of a Phase II/III clinical trial for Pazopanib. Review by the ACCME has determined Cure HHT is not an ineligible company. This disclosure has been mitigated.

Scroll To Top